The Omicron Wave in India, Mumbai, and Delhi: Prevalence and Pathogenicity

Zameer Shervani, Deepali Bhardwaj, Sadia Hasan, Umair Yaqub Qazi, Manseej Purang, Aiman Ibbrahim, Venkata Phani Sai Reddy Vuyyuru, Arif Siddiquie, Abdullah Sherwani, Adil Ahmed Khan, Kehkeshan Fatma, Samar Siddiqui, Nudrat Jamal and Shazma Khan
Additional contact information
Zameer Shervani: Food and Energy Securities, Japan
Deepali Bhardwaj: Centre for Skin and Hair Pvt. Ltd., India
Sadia Hasan: Jamia Millia Islamia, India
Umair Yaqub Qazi: University of Hafr Al Batin, K.S.A.
Manseej Purang: Darne Clinic, Mauritius
Aiman Ibbrahim: Aligarh Muslim University, India
Venkata Phani Sai Reddy Vuyyuru: Citizens Speciality Hospital and American Oncology Institute, India
Arif Siddiquie: Amity University, India
Abdullah Sherwani: Aligarh Muslim University, India
Adil Ahmed Khan: All India Institute of Medical Sciences, (AIIMS), India
Kehkeshan Fatma: Aligarh Muslim University, India
Samar Siddiqui: Medanta Hospital, India
Nudrat Jamal: Genomia Diagnostics Research Pvt. Ltd., India
Shazma Khan: Santosh Medical College, India

European Journal of Medical and Health Sciences, 2022, vol. 4, issue 3, 123-130

Abstract: The dynamics of the Omicron variant in India, Mumbai, and Delhi have been studied. The % share of the Omicron variant in overall India rose from 0.35% to 97.12% during the period November 29, 2021, to February 7, 2022. Due to the emergence of the Omicron variant, the daily new infections in India rose from a baseline tally of below 8,000 cases to the highest number of 347,063 cases recorded on January 20, 2022. In Mumbai, the Omicron variant completely replaced the Delta and other lineages as reported on March 3, 2022 genome sequencing report. In Mumbai because of the Omicron variant surge, the new infections rose to 20,971 on January 7, 2022, from a baseline tally of 191 daily cases recorded after receding the second Delta variant wave. In real-time, the vaccine effectiveness among the Indian population during the Omicron variant surge was studied and noticed that the two-dose regimen was 99.3% effective in preventing death. The death rate among the hospitalized patients was reduced by 12% among the vaccinated individuals compared to the unvaccinated ones. During the Omicron variant wave, the average age of the COVID-19 patients shifted by 11 years towards the younger age which was because the vaccination among the younger population was low compared to the elderly population.

Keywords: Mortalities prevention; Omicron pathogenicity; Omicron variant; spread dynamics; vaccine effectiveness (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://eu-opensci.org/index.php/ejmed/article/view/41376 Abstract page (text/html)
https://eu-opensci.org/index.php/ejmed/article/download/41376/9467 Full text (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:epw:ejmed0:v:4:y:2022:i:3:id:41376

DOI: 10.24018/ejmed.2022.4.3.1376

Access Statistics for this article

More articles in European Journal of Medical and Health Sciences from European Open Science
Bibliographic data for series maintained by Support ().